BRCA2 and neoplasm: Having shown that DNA damage is increased in olaparib-resistant tumours, we next analysed whether HRR could have been restored to repair this damage [7, 9, 18], although unlikely in our model, given the permanent nature of deletion of the Brca2 conditional allele.